Short communicationThe effect of n-3 polyunsaturated fatty acids on Lp(a)
References (25)
- et al.
Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART)
Lancet
(1989) - et al.
Fish oil consumption and decreased risk of cardiovascular disease: a comparison of findings from animal and human feeding trials
Am J Clin Nutr
(1986) Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review
J Lipid Res
(1989)- et al.
Lipoprotein Lp(a) and the risk of myocardial infarction
Atherosclerosis
(1981) - et al.
The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis
Atherosclerosis
(1986) - et al.
The effect of n-3 polyunsaturated fatty acids on lipids, platelet function, coagulation, fibrinolysis and monocyte chemotaxis in patients with hypertension
Clin Chim Acta
(1990) - et al.
Apolipoproteins (a), A1, and B and parenteral history in men with early onset ischaemic heart disease
Lancet
(1988) - et al.
Cod liver oil inhibits neutrophil and monocyte chemotaxis in healthy males
Atherosclerosis
(1989) - et al.
Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a)
Atherosclerosis
(1982) - et al.
Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment
Atherosclerosis
(1985)
Influence of dietary fish oils on Lp(a) levels
Thromb Res
Prophylaxis of atherosclerosis with marine omega-3 fatty acids
Ann Intern Med
Cited by (42)
Absolute quantification of apolipoproteins following treatment with omega-3 carboxylic acids and fenofibrate using a high precision stable isotope-labeled recombinant protein fragments based SRM assay
2019, Molecular and Cellular ProteomicsCitation Excerpt :In this study, no effects on apo(a) concentrations were observed, whereas previous fenofibrate studies have shown either no change in apo(a) levels (33, 39) or an increase in apo(a) levels (42). Previous OM3-CA treatment studies either observed no change or decreased apo(a) levels (40, 41). Apo(a) is highly variable in structure and size (63).
Correlates of lipoprotein(a) levels in a biracial cohort of young girls [1]
2000, Journal of PediatricsCitation Excerpt :In the study by Kimm et al,1 only the Keys’ score was calculated, and there was no evaluation of trans fatty acid intake. Furthermore, n-3 fatty acids may affect Lp(a) levels,3,4 although in this study the dietary intake of n-3 fatty acids was not assessed. The authors state that the marginal association between Lp(a) levels and adiposity is intriguing because in most studies Lp(a) is not affected by anthropometric measures (body mass index, waist-hip ratio, skinfold thickness).
Comparison of effects of N-3 to N-6 fatty acids on serum level of lipoprotein(a) in patients with coronary artery disease
1995, The American Journal of CardiologyVitamin E supplementation counteracts the fish oil-induced increase of blood glucose in humans
1995, Nutrition ResearchNo changes in PAI-1 levels after four-month n-3 PUFA ethyl ester supplementation in healthy subjects
1994, Thrombosis ResearchStructure and Possible biological roles of Lp(a)
1994, Clinical Biochemistry